About LensAR
LensAR is a publicly listed company based in Orlando (United States) founded in 2004, and was acquired by Alcon in March 2025. Laser and 3D imaging technology for cataract surgery is developed. LensAR has raised $99.01 million across 14 funding rounds from investors including Alcon, Oxford Finance and ALPHAEON. The company has 140 employees. LensAR offers products and services including ALLY Robotic Cataract Laser System and LENSAR Laser System. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is LENSAR, Inc. Its competitors include SentiAR, Enhatch and ZSFab; 3 of its 3 listed competitors have raised funding.
Company details
LensAR was founded in 2004 and is based in Orlando, United States. Operations focus on the development and commercialization of laser systems and advanced 3D imaging for refractive cataract procedures within the medical technology sector. The LensAR Laser System has received FDA clearance for anterior capsulotomy and lens fragmentation tasks. Activities center on enhancing surgical precision through integrated technologies.
- Headquarters Orlando, United States
- Employees 140
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website lensar.com
- Social LinkedIn X Facebook
- Acquired by Alcon (Mar 2025)
- Legal Name Lensar, Inc.
- Annual Revenue$58.44 M (USD)9.24as on Dec 31, 2025
- Net Profit-$34.28 M (USD)-9.16as on Dec 31, 2025
- EBITDA-$20.08 M (USD)-568.09as on Dec 31, 2025
- Total Equity Funding$99.01M (USD)
in 14 rounds
- Latest Funding Round$20M (USD), Post-IPO
May 2023
- InvestorsAlcon
& 5 more
- Employee Count140
- Acquired by
Products & Services of LensAR
LensAR offers a comprehensive portfolio of products and services, including ALLY Robotic Cataract Laser System and LENSAR Laser System.
Robotic system for precise cataract surgery and better patient recovery.
Platform for advanced cataract treatment and surgical guidance.
Funding Insights of LensAR
LensAR has successfully raised a total of $99.01M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $99.01M
- Total Rounds 14
- Last Round Post-IPO — $20M
- First Round $7.1M
(Aug 2009)
- Investors Count 4
Latest 10 of 14 funding rounds of LensAR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $20M | Post-IPO | – | – | – |
| Jan 2015 | $16M | Series D | – | – | – |
| Jan 2014 | $10M | Series C | – | – | – |
| Oct 2013 | $60M | Debt – Conventional | – | – | |
| Aug 2013 | $17.44M | Series C | – | – | – |
| Dec 2012 | $5M | Series B | – | – | – |
| Jul 2012 | $10M | Debt – Conventional | – | – | |
| Mar 2012 | $24.05M | Series B | – | Aisling Capital, Florida Growth Capital | – |
| Dec 2011 | $1.43M | Series A | – | – | – |
| Oct 2011 | $4M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in LensAR
LensAR has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Oxford Finance and ALPHAEON.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biopharmaceutical company undergoing dissolution and asset distribution processes. | pdl.com | |||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
PE firm investing in the US | aislingcapital.com | New York, United States | ||
| floridagrowthfund.com | ||||
Developer of a wide range of eye care products | 1945 | alcon.com | Fort Worth, United States | |
Healthcare financing is provided through treatment-based loans with fixed terms. | 2013 | alphaeon.com | Irvine, United States |
Investor details for LensAR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LensAR
30 people are tracked at LensAR (9 in leadership, 9 in board & advisors, 12 in team); the tracked headcount is 140.
| Name | Role | Group |
|---|---|---|
Jimmy Strobel | Senior Director Of Technical Services | Leadership |
Don Brydon | Director Of Phaco Market Development | Leadership |
Nicholas T. Curtis | Chief Executive Officer | Leadership |
Tom Staab | Chief Financial Officer | Leadership |
Natalie Lange | Director Of Finance | Leadership |
Alan Connaughton | Chief Operating Officer | Leadership |
Lauren Gyoerkoe | Sr. Vice President Of Global Marketing | Leadership |
Keith Peck | Vice President Of Quality | Leadership |
Dara O'Suilleabhain | Senior Director Of Manufacturing | Leadership |
Mitchell A. Jackson | Advisor | Board & advisors |
Denise Visco | Advisor | Board & advisors |
Warren Hill | Advisor | Board & advisors |
Gregory D. Parkhurst | Advisor | Board & advisors |
William B. Trattler | Advisor | Board & advisors |
Mark Packer | Advisor | Board & advisors |
Carlos Buznego | Advisor | Board & advisors |
Robert J. Weinstock | Advisor | Board & advisors |
Elizabeth Yeu | Advisor | Board & advisors |
Stefani MacRi | Senior Human Resources Generalist | Team |
John Fletcher | Senior Marketing Communications Manager | Team |
10 more people are available in the full profile.
Complete people profiles for LensAR
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of LensAR
LensAR is a publicly listed company on the NASDAQ with ticker symbol LNSR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 Oct 2020
- Listed onNASDAQ: LNSR
- Listed entityLENSAR, Inc.
- Exchange sectorHealth technology
- ISINUS52634L1089
- Share price$6.27 (+0.8% on the day) · 2026-10-13
- Market capitalisation$77.0M
- EPS (diluted, trailing year)$-0.33
- Volume (last session)23,868
Financials of LensAR
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $58.4M | -$34.3M | -$20.1M |
| 2024 | $53.5M | -$31.4M | -$3.0M |
| 2023 | $42.2M | -$14.4M | -$8.7M |
| 2022 | $35.4M | -$19.9M | -$16.2M |
| 2021 | $34.5M | -$19.6M | -$16.4M |
Detailed financial statements for LensAR
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of LensAR
6 dated milestones of LensAR across 21 years, from founding to its latest funding, stage changes and deals.
Competitors of LensAR
LensAR has 3 listed competitors in our database, 3 of them funded. They include SentiAR, Enhatch and ZSFab.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentiar.com | 2017 | St. Louis, United States | $26.76M | 8 | A 3D visualization platform is offered for interventional cardiac procedures. | |
| enhatch.com | 2012 | Hoboken, United States | $9.99M | 16 | Provider of mobile enterprise apps for Salesforce | |
| zsfab.com | 2017 | Cambridge, United States | $2.5M | Customized orthopedic implants are designed using AI-driven 3D printing software. |
Detailed competitors of LensAR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LensAR
The website of LensAR (lensar.com) receives about 4.6K visits a month.
- Monthly visits4.6K
▼ 16.4% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as LensAR (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lensar
Complete news archive for LensAR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LensAR
LensAR was founded in 2004 and raised its 1st funding round 5 years after it was founded.
LensAR is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
LensAR is a funded company, having raised a total of $99.01M across 14 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Aug 2009.
LensAR has 140 employees.
Annual revenue of LensAR is $58.44M as on Dec 31, 2025.
LensAR was founded in 2004 and is based in Orlando, United States. Operations focus on the development and commercialization of laser systems and advanced 3D imaging for refractive cataract procedures within the medical technology sector. The LensAR Laser System has received FDA clearance for anterior capsulotomy and lens fragmentation tasks. Activities center on enhancing surgical precision through integrated technologies.
LensAR offers ALLY Robotic Cataract Laser System and LENSAR Laser System.
Yes, LensAR is publicly traded on NASDAQ under the ticker symbol LNSR.
LensAR has 6 investors. Key investors include Alcon, Oxford Finance, ALPHAEON, PDL BioPharma, and Aisling Capital.
LensAR operates through Lensar, Inc..
Yes. LensAR was acquired by Alcon in March 2025.